C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation-Reference-Cited by-同舟云学术

C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation

Published:2017-09-05 Issue:3 Volume:32 Page:828-836
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Marneth A E,Prange K H M,Al Hinai A S A,Bergevoet S M,Tesi N,Janssen-Megens E M,Kim B,Sharifi N,Yaspo M L,Kuster J,Sanders M A,Stoetman E C G,Knijnenburg J,Arentsen-Peters T C J M,Zwaan C M,Stunnenberg H G,van den Heuvel-Eibrink M M,Haferlach T,Fornerod M,Jansen J H,Valk P J M,van der Reijden B A,Martens J H A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017280.pdf

Reference41 articles.

1. Hinai AA, Valk PJ . Review: aberrant EVI1 expression in acute myeloid leukaemia. Br J Haematol 2016; 172: 870–878.

2. Groschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BA, Erpelinck C et al. A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 2014; 157: 369–381.

3. Yamazaki H, Suzuki M, Otsuki A, Shimizu R, Bresnick EH, Engel JD et al. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell 2014; 25: 415–427.

4. Senyuk V, Sinha KK, Li D, Rinaldi CR, Yanamandra S, Nucifora G . Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis. Cancer Res 2007; 67: 5658–5666.

5. Laricchia-Robbio L, Fazzina R, Li D, Rinaldi CR, Sinha KK, Chakraborty S et al. Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells. Mol Cell Biol 2006; 26: 7658–7666.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neuronal homeobox transcription factor HMX3 is a crucial vulnerability factor in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia;2023-11-09

2. High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia;Leukemia;2023-02-18

3. Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation;Molecular Medicine Reports;2019-11-26

4. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair;Clinical Epigenetics;2019-10-07

5. C-terminal BRE inhibits cellular proliferation and increases sensitivity to chemotherapeutic drugs of MLL-AF9 acute myeloid leukemia cells;Leukemia & Lymphoma;2019-05-21